top of page

Sheet Mask Compliance in China, the US, the EU, and ASEAN

Aug 4
9 min read

Updated: Sep 14

What Are the Four Regulatory Models Behind Sheet Mask Compliance?

Sheet mask compliance splits into four separate legal systems, and a mask that clears one often fails another. China runs pre-market filing with a special-cosmetics tier for certain claims, the EU runs notification plus a safety file that stays with the responsible person, the US runs facility registration and product listing under MoCRA, and ASEAN runs a harmonized notification scheme that each member state applies on its own schedule. The four systems share almost no paperwork.

The commercial consequence is blunt. A formula built for one market usually needs a second variant before it can ship to a third. Brands that plan for this at the brief stage spend one development cycle. Brands that discover it at customs spend a reformulation cycle plus a compliance hold.

China: NMPA filing and special cosmetics registration

China classifies masks by claim rather than by form. A hydrating sheet mask places under the notification system. A mask that claims spot fading, whitening, or anti-hair loss must register as a special cosmetic, which adds a longer review track and requires supporting data before submission. The governing framework is the Cosmetic Supervision and Administration Regulation together with the Safety and Technical Standards for Cosmetics.

The practical trigger sits in marketing copy. If your brand plan includes a brightening claim on a sheet mask, budget the registration timeline into the launch date rather than treating it as a later add-on.

European Union: CPNP notification and the Product Information File

The EU regulates after market entry but demands a complete dossier before it. Regulation (EC) No 1223/2009 requires the responsible person to notify the product through the Cosmetic Products Notification Portal and to hold a Product Information File that includes a Cosmetic Product Safety Report signed by a qualified safety assessor. The file must be available to authorities on request, and it must stay current.

A sheet mask carries particular weight here because it is a leave-on product at high water activity. Both factors make the preservative system and the substrate chemistry central to the safety assessment.

United States: MoCRA facility registration and product listing

The US FDA operates under MoCRA, the Modernization of Cosmetics Regulation Act of 2022. Cosmetic manufacturing facilities must register with the FDA, each product must be listed, and the responsible party must hold adequate substantiation that the product is safe. MoCRA enforcement now covers the full registration and listing workflow.

For a brand sourcing from overseas, this makes factory registration status a sourcing question rather than a paperwork detail. A manufacturer that cannot supply its registration details cannot support your listing.

ASEAN: the ASEAN Cosmetic Directive and national notification

ASEAN members apply the ASEAN Cosmetic Directive, which harmonizes ingredient annexes across member states. Notification still happens country by country. The ingredient annexes track the EU list closely, but approval timelines and documentation expectations differ, so the sequence of market entry matters as much as the formula itself.

DEVA-skincare-sheet-mask-cross-border-compliance-pathway

How Do Substrate Rules Differ Across Markets?

The sheet mask substrate moved from an afterthought to a regulated component. The EU treats it through chemical restriction, while China, the US, and ASEAN treat it mainly as a material in direct contact with the product.

EU: synthetic microplastics in leave-on products

Regulation (EU) 2023/2055 amends Annex XVII of the REACH Regulation and restricts intentionally added synthetic microplastics. Sheet masks are leave-on products. Several conventional non-biodegradable water-soluble polymers used as thickeners or film formers fall inside the scope, with phase-out periods that differ by use category.

EU-bound masks therefore move toward biodegradable substrates such as Lyocell, Cupro, and bio-cellulose, and toward thickener systems that avoid restricted synthetics. This is a formulation decision, not a packaging decision, because the thickener sits in the essence.

China, the US, and ASEAN: food-contact material safety

These three markets focus on whether the material that touches the product releases harmful substances. China requires packaging materials in direct contact with cosmetics to comply with the General Requirements for Packaging Materials in Direct Contact with Cosmetics and the related national standards, which caps migration of heavy metals and plasticizers. The working test is migration and compatibility, not biodegradability.


What Are the Regulatory Boundaries for Sheet Mask Preservatives and Actives?

A sheet mask is a high-aqueous leave-on product, which makes its preservative system the single most scrutinized part of the formula. The table below shows where the four markets diverge.

Preservative limits that decide whether a mask passes

Preservative

EU

China

US

ASEAN

Methylisothiazolinone (MIT)

Banned in all leave-on cosmetics

Not permitted in leave-on products

Restricted to rinse-off

Follows the EU restriction

Parabens

Type and concentration limits apply

Positive list with concentration limits

Permitted under the monograph limits

Annex VI concentration limits

Methylchloroisothiazolinone / MIT mixture

Rinse-off only

Rinse-off only

Rinse-off only

Rinse-off only

Phenoxyethanol

Permitted up to 1%

Positive list, 1% limit

Permitted, 1% typical use level

Annex VI limit

Hydroxyacetophenone and 1,2-hexanediol blends

Used as multifunctional ingredients, not listed as preservatives

Must be justified by intended function and safety assessment

Accepted as non-preservative multifunctional ingredients

Accepted, assessed per Annex VI scope

 

The last row causes the most reformulation work. A blend that functions as a preservative in practice but is declared as a moisturizer invites a labeling question in the EU and China, because the intended function and the declared function must match. Mask formulas that rely on these blends need the function stated honestly in the filing.

Repair actives with the widest cross-border acceptance

Panthenol and Ectoin hold the highest safety ratings across all four markets, which makes them useful anchors for a mask essence meant to travel.

Active

Typical use level

Function in a sheet mask essence

Cross-border status

Panthenol (provitamin B5)

1-5%

Keratinocyte support, humectancy, barrier comfort

No regional restriction at these levels

Ectoin

0.5-2%

Hydration shell formation, stress protection

No regional restriction at these levels

Sodium hyaluronate

0.05-0.5%

Surface hydration, sensory slip

No regional restriction

Centella asiatica extract

0.5-2%

Soothing support

Check the extract's listed status per market

Niacinamide

2-5%

Barrier support, tone support

Concentration limits differ; verify the claim tier

 

Panthenol and Ectoin qualify as safe across markets because their safety assessments do not create regional conflict. Extracts and tone-support actives need a per-market status check, because the same extract can sit in a permitted list in one market and outside it in another.


What Claim Evidence Does Each Market Require for Sheet Masks?

Market

Governing framework

What counts as evidence

What does not count

China

Specifications for Cosmetic Efficacy Claim Evaluation

Human efficacy evaluation reports for anti-wrinkle, firming, and repair claims

In-vitro cell data or supplier data alone

China

Specifications for Cosmetic Efficacy Claim Evaluation

Literature, research data, or efficacy tests for moisturizing claims

Unsubstantiated marketing language

EU

Regulation (EU) No 655/2013 Common Criteria

Evidence held by the responsible person, covering legality, truthfulness, honesty, fairness, and substantiation

Free-from claims framed as a safety signal

US

FTC reasonable basis standard

At least two rigorous independent studies; human clinical reports for clinically proven claims

Single study or supplier summary

ASEAN

ASEAN Cosmetic Claims Guide

Cosmetic-scope language such as helps to improve

Medical terms such as treat, cure, and anti-inflammatory

 

Two rules carry the most weight in practice. China requires human efficacy evaluation reports for anti-wrinkle, firming, and repair claims, so a cell study cannot substitute. The FTC expects at least two rigorous independent studies before a claim goes live, which sets a higher bar than the ingredient supplier's product sheet.

Against those bars, a mask brand should decide which claims it actually needs before the formula is locked. A claim that requires a human study adds four weeks of testing, and a claim that crosses into medical language fails in ASEAN regardless of the data behind it.

How Does Sheet Mask Compliance Change the Formulation Brief?

The brief is where compliance gets cheap or expensive. Five decisions at the brief stage determine how many formula variants you need.

Brief decision

Why it drives cost

What to specify upfront

Essence platform

Determines preservative system and thickener choice

Target markets first, then water activity and pH range

Substrate material

EU restricts certain synthetic polymers

Biodegradable fiber if the EU is in scope

Thickener system

EU microplastics restriction applies to the essence

Avoid restricted synthetics from the first prototype

Claim set

Determines whether a human study is required

One claim list per market, not one global list

Pack format

Affects material migration testing for direct contact

Food-contact compliance evidence from the sachet supplier

 

The single most expensive mistake is a global claim list. A claim that clears the FTC bar requires at least two independent studies; the same claim in ASEAN cannot use medical language. Writing the claim list per market before the first prototype costs a planning meeting. Writing it after the formula is locked costs a reformulation cycle.

Which Testing and Documentation Steps Take the Longest?

Testing drives the schedule, and most of it cannot overlap because a stability result gates the safety file.

Step

Output

Typical duration

Blocks what

Formula development and stability testing

Stability protocol results, shelf-life basis

4 weeks

The safety report, which needs stability data

In-vitro panel testing

Cytotoxicity and irritation data

4 weeks

Claim substantiation and the safety report

28-day human use test

Human efficacy and tolerance report

4 weeks

Anti-wrinkle, firming, and repair claims in China

Preservative efficacy challenge test

Preservation system validation

4 weeks

The product information file

Compatibility testing across multiple actives

Actives interaction data

4 weeks

Final essence confirmation

Product Information File and safety report

EU dossier ready for CPNP notification

Overlaps the above

Market entry in the EU

Sample approval to mass production

Production batch

6 weeks after sample approval

Launch date

 

Samples take one week. Mass production takes six weeks after sample approval. Each test protocol takes about four weeks. A mask targeting China with an anti-wrinkle claim and the EU with a safety file should plan roughly one quarter from brief approval to a shippable batch, with the China human study and the EU safety report running in parallel rather than in sequence.

How Do You Vet a Manufacturer for Sheet Mask Compliance?

Four questions separate a manufacturer that can support multi-market masks from one that can only fill a formula.

Facility registration and certification. Ask for FDA cosmetic manufacturer registration status, ISO 22716, and GMPC documentation. MoCRA makes facility registration a direct part of your product listing, so the manufacturer's status becomes your status. DEVA Skincare holds FDA cosmetic manufacturer registration granted in 2023, ISO 22716, and GMPC, and runs four manufacturing sites with a combined monthly capacity above 20 million units.

Ingredient screening capability. Ask which regulatory databases the manufacturer screens against, and whether screening happens at the prototype stage or after the formula is fixed. DEVA Skincare screens the full ingredient list against global regulatory databases at prototyping, flagging restricted substances such as EU-restricted microplastics and banned preservatives before the formula is locked.

Testing depth. Ask how many test protocols the manufacturer can run in-house and which ones go to third parties. DEVA Skincare runs 150 efficacy and safety test protocols covering cell efficacy and toxicity, CAM irritation, melanin inhibition, and preservative challenge, with 72 inspection and process control steps in production. Six laboratories cover cell testing, product efficacy evaluation, plant extraction and fermentation, active ingredient analysis, packaging testing, and heavy metal testing.

Regulatory documentation. Ask who drafts the safety report and whether the manufacturer has a regulatory affairs function or outsources the whole file. DEVA Skincare maintains a regulatory affairs team that compiles the Product Information File and coordinates the Cosmetic Product Safety Report with licensed assessors.

A mask line for China, the US, the EU, and ASEAN starts with the formula brief and the claim list, not with the substrate. Send your target markets and claim set through the inquiry form below, and our regulatory affairs and R&D team will map the ingredient, substrate, and documentation path for your sheet mask project.

How long does sheet mask compliance take across four markets?

Four markets require separate filings and cannot share one timeline. China special cosmetics registration runs longest, and anti-wrinkle or firming claims add a 28-day human study. Sampling takes one week and mass production six weeks after approval. Plan roughly one quarter for a single market with claims, and longer when four markets run in sequence.

Standard MOQ is 5,000 units. Sheet masks carry a higher threshold of 50,000 units because the sachet filling line runs at a different batch scale. Aluminum cans start at 10,000 units and ampoules at 200,000 units. Sampling takes one week and mass production takes six weeks after sample approval.

Yes, but both claims move the product into a stricter tier. Whitening and spot-fading require special cosmetics registration. Anti-wrinkle, firming, and repair claims require a human efficacy evaluation report, and in-vitro or supplier data does not substitute. Budget the registration and the four-week human study into your launch schedule.

Methylisothiazolinone is banned in all leave-on cosmetic products in the EU, and the methylchloroisothiazolinone and methylisothiazolinone mixture is restricted to rinse-off products. Parabens face type and concentration limits. Multifunctional blends such as hydroxyacetophenone and 1,2-hexanediol are accepted, but the declared function must match the intended function in the filing.

Yes. MoCRA requires cosmetic manufacturing facilities to register with the FDA and each product to be listed, with adequate safety substantiation held by the responsible party. If your manufacturer is overseas, its registration status becomes part of your listing requirement, so verify it during sourcing rather than after the formula is locked.

Rarely without adjustment. The EU microplastics restriction drives the thickener and substrate choice, China's claim tiers drive registration, the FTC bar drives the study count, and ASEAN language rules limit claim wording. Most brands ship one base essence with market-specific preservative and claim variants rather than a single global formula.


Comments


bottom of page